Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restor... Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.01 | -0.826446280992 | 1.21 | 1.27 | 1.13 | 79239 | 1.17451171 | CS |
| 4 | -0.11 | -8.39694656489 | 1.31 | 1.94 | 1.13 | 214106 | 1.48411874 | CS |
| 12 | 0.08 | 7.14285714286 | 1.12 | 1.94 | 1.06 | 164396 | 1.34429681 | CS |
| 26 | -2.6 | -68.4210526316 | 3.8 | 3.95 | 0.94 | 406184 | 1.4585886 | CS |
| 52 | -8.34 | -87.4213836478 | 9.54 | 11.76 | 0.94 | 372614 | 3.56385819 | CS |
| 156 | -3.98 | -76.833976834 | 5.18 | 11.76 | 0.94 | 326273 | 4.79349343 | CS |
| 260 | -17.41 | -93.551853842 | 18.61 | 60.5162 | 0.94 | 290030 | 8.98764665 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
